![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
XTL Biopharmaceuticals Ltd | NASDAQ:XTLB | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.2733 | 10.16% | 2.9633 | 2.65 | 3.49 | 3.04 | 2.71 | 2.71 | 81,218 | 21:03:53 |
XTL
BIOPHARMACEUTICALS LTD.
|
||
Date:
August 27, 2008
|
By:
|
/s/
Ron Bentsur
|
Ron
Bentsur
|
||
Chief
Executive Officer
|
Exhibit
Number
|
Description
|
|
99.1
|
Press
Release dated August 27, 2008.
|
|
99.2
|
Notice
of Extraordinary General Meetings
|
|
99.3
|
Proxy
Form for use at the Extraordinary General Meetings of the Company
to be
held on October 2, 2008
|
1 Year XTL Biopharmaceuticals Chart |
1 Month XTL Biopharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions